Drug Topics - January 2009 - (Page 12) Letters All states should regulate pharmacy technicians good pharmacists, but they do not make the best pharmacists. Most that I know are tired from filling $4 scripts. Many independents, hospitals, and other chains also may have great pharmacists. Please do not insult me by saying Wal-Mart and only Wal-Mart makes great pharmacists. Steve Jenkins, PharmD FAYETTEVILLE, ARK. In reference to the November 10, 2008 article [“Florida joins states regulating pharmacy technicians”], my kudos to Michael Jackson, executive vice president of the Florida Pharmacists Association, for all of his hard work in helping to enact legislation [that] will require all technicians working in Florida to become trained and certified. Unfortunately, for me and thousands of pharmacists who work in the other eight unregulated states, the disparity of skill level among technicians is unbelievable. I work for a supermarket chain in one of the unregulated states as a floater. There are some stores in the company that have excellent technical staff and others where the staff lacks the most basic skills needed to function at a borderline level, making the pharmacist’s job more demanding than it needs to be. When will these other states get on board with the more than 80 percent of states that have or will soon adopt regulations? When will they realize that the quality of care given to patients depends upon the quality of technicians assisting their pharmacists in today’s pharmacy arena? Richard Phillips, MS, RPh NEW YORK, N.Y . Wal-Mart model not the best one This is about your article in the November 10 issue [“West Virginia university program welcomes WalMart pharmacy”]. Ed Welch was quoted as saying, “Our students will learn in a real pharmacy how to be a real pharmacist.” I laughed until it hurt. I have been a pharmacist for more than 32 years and I have worked both hospital and retail. It was the people that I worked with, not the company, who taught me and inspired me to be the pharmacist I am today. Wal-Mart may be big, but it is not necessarily right. Wal-Mart may have I am shocked that anyone would invite Wal-Mart to their university It just proves how out of touch universities are with real-world pharmacy. Anyone who is proud of their profession would cringe at the thought of Wal-Mart warping the minds of pharmacy students into thinking that what they do in their pharmacies is what should be practiced anywhere else. Wal-Mart is all about destroying the profession with cutthroat, deceptive pricing policies. Many of the new pharmacists actually think the $4 [prescription] is really great — that is, until they find out they will soon be replaced by a tech because of it. It is a lot like the mortgage meltdown and the zero-down loan. At some point, someone has to pay the bill. Randy Armbruster, RPh SLEEPY EYE, MINN. We Want To Hear From You Printed and e-mailed letters should be brief and include the writer’s name, address, daytime phone number, and date of the issue you are referencing: Editor, Drug Topics, 24950 Country Club Blvd., Suite 200, North Olmsted, OH 44070-5351. E-mail address: drugtopics@advanstar.com. Letters may be edited for length, style, content, and clarity at our discretion. 12 DRUG TOPICS Januar y 2009 W W W.D R U GTO P I C S .C O M http://WWW.DRUGTOPICS.COM
Table of Contents Feed for the Digital Edition of Drug Topics - January 2009 Drug Topics - January 2009 Contents Letters Up Front Up Front in Depth Community Practice Drug Pipeline: What to Watch in 2009 OTC Community-Aquired MRSA Infections New Products Viewpoint Drug Topics - January 2009 Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page Cover2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 1) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 2) Drug Topics - January 2009 - Drug Topics - January 2009 (Page 3) Drug Topics - January 2009 - Contents (Page 4) Drug Topics - January 2009 - Contents (Page 5) Drug Topics - January 2009 - Contents (Page 6) Drug Topics - January 2009 - Contents (Page 7) Drug Topics - January 2009 - Contents (Page 8) Drug Topics - January 2009 - Contents (Page 9) Drug Topics - January 2009 - Contents (Page 10) Drug Topics - January 2009 - Contents (Page 11) Drug Topics - January 2009 - Letters (Page 12) Drug Topics - January 2009 - Letters (Page H1) Drug Topics - January 2009 - Letters (Page H2) Drug Topics - January 2009 - Letters (Page H3) Drug Topics - January 2009 - Letters (Page H4) Drug Topics - January 2009 - Letters (Page H5) Drug Topics - January 2009 - Letters (Page H6) Drug Topics - January 2009 - Letters (Page H7) Drug Topics - January 2009 - Letters (Page H8) Drug Topics - January 2009 - Letters (Page 13) Drug Topics - January 2009 - Up Front (Page 14) Drug Topics - January 2009 - Up Front (Page 15) Drug Topics - January 2009 - Up Front (Page 16) Drug Topics - January 2009 - Up Front (Page 17) Drug Topics - January 2009 - Up Front in Depth (Page 18) Drug Topics - January 2009 - Up Front in Depth (Page 19) Drug Topics - January 2009 - Community Practice (Page 20) Drug Topics - January 2009 - Community Practice (Page 20a) Drug Topics - January 2009 - Community Practice (Page 20b) Drug Topics - January 2009 - Community Practice (Page 21) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 22) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 23) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 24) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 25) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 26) Drug Topics - January 2009 - Drug Pipeline: What to Watch in 2009 (Page 27) Drug Topics - January 2009 - OTC (Page 28) Drug Topics - January 2009 - OTC (Page 29) Drug Topics - January 2009 - OTC (Page 30) Drug Topics - January 2009 - OTC (Page 31) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 32) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 33) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 34) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 35) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 36) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 37) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 38) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 39) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 40) Drug Topics - January 2009 - Community-Aquired MRSA Infections (Page 41) Drug Topics - January 2009 - New Products (Page 42) Drug Topics - January 2009 - New Products (Page 43) Drug Topics - January 2009 - New Products (Page 44) Drug Topics - January 2009 - New Products (Page 45) Drug Topics - January 2009 - New Products (Page 46) Drug Topics - January 2009 - New Products (Page 47) Drug Topics - January 2009 - Viewpoint (Page 48) Drug Topics - January 2009 - Viewpoint (Page Cover3) Drug Topics - January 2009 - Viewpoint (Page Cover4)
For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.